SCD care has improved in recent years especially with hydroxyurea, still a lot needs to be done for early diagnosis and newborn screening in developing countries. Globally we are becoming more aware of the issues pertaining to sickle cell, now, where is the funding to do something about it? There is slow but steady progress. Clearly the problem being addressed is complex and is hard to tackle. I attended the 3rd Global Congress Meeting in India and was impressed with the increasing awareness and discovering a number of dedicated individuals trying to make a difference.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.